A new protein-linked dye derived from scorpion venom that lights up cancer cells so surgeons can precisely target brain tumors will get a trial run in the U.S. Fred Hutch file photo
The FDA has given a green light for the first U.S. trial
of Tumor Paint BLZ-100, a molecule derived from scorpion venom that illuminates
cancer cells. Fred Hutch’s Dr. Jim Olson led its discovery and development.
Doing some shopping
at Fred Meyer? Register for a rewards card and link it to Fred Hutch. You’ll
earn rewards for our research and your family every time you shop.